Regn investor notice: regeneron pharmaceuticals, inc. investors with substantial losses have opportunity to lead investor class action lawsuit

San diego , jan. 29, 2025 /prnewswire/ -- the law firm of  robbins geller rudman & dowd llp announces that purchasers or acquirers of regeneron pharmaceuticals, inc. (nasdaq: regn) securities between november 2, 2023 and october 30, 2024, inclusive (the "class period"), have until monday, march 10, 2025 to seek appointment as lead plaintiff of the regeneron class action lawsuit.  captioned radtke v.
REGN Ratings Summary
REGN Quant Ranking